Pharmacy Immunizations and Vaccines 3

Question 1

The National Vaccine Injury Compensation Program (VICP) is funded by an excise tax on vaccines and covers injuries from which vaccines?

Accepted Answer

All vaccines recommended by ACIP for routine administration, including adult vaccines

Answer

VICP covers all vaccines on the Vaccine Injury Table, which includes many ACIP-recommended vaccines for both children and adults. It provides a no-fault compensation process.

Question 2

Post-exposure prophylaxis (PEP) for hepatitis B includes:

Accepted Answer

HBIG and initiation of hepatitis B vaccine series simultaneously at different sites

Answer

Unvaccinated persons exposed to hepatitis B should receive HBIG (provides immediate passive immunity) and begin the hepatitis B vaccine series simultaneously at different injection sites.

Question 3

When documenting vaccine administration, which information is required under federal law (NCVIA)?

Accepted Answer

The vaccine manufacturer, lot number, site/route, date, and the VIS edition date given

Answer

NCVIA requires documentation of: vaccine name/manufacturer, lot number, date given, name/address of administering provider, and the edition date of the VIS provided — all in the patient's permanent medical record.

Question 4

A patient with egg allergy asks about receiving the influenza vaccine. Current ACIP guidance states:

Accepted Answer

Patients with egg allergy may receive any licensed flu vaccine appropriate for their age — standard observation period applies

Answer

ACIP removed special precautions for egg-allergic patients receiving influenza vaccine. Any licensed flu vaccine appropriate for age can be administered with the standard post-vaccination observation period (15 minutes).

Question 5

Meningococcal B vaccination (MenB) differs from MenACWY in that ACIP recommends MenB as:

Accepted Answer

An individualized clinical decision for persons 16–23 years old (shared clinical decision-making)

Answer

MenACWY is routinely recommended at 11–12 with booster at 16. MenB is a 'shared clinical decision' recommendation for healthy adolescents 16–23 (preferably 16–18), not universally routine, given after weighing risks.

Pharmacy Practice Test

Pharmacy Practice Test

Pharmacy Immunizations and Vaccines 3